HbS 70% on HPLC: Diagnostic Interpretation
A hemoglobin S level of 70% on HPLC most likely indicates sickle β⁺-thalassemia (HbS/β⁺-thal) compound heterozygosity, though homozygous sickle cell disease (HbSS) remains possible if the patient has recently been transfused or has elevated fetal hemoglobin.
Understanding the HbS Percentage
The 70% HbS level falls into a diagnostic gray zone that requires careful interpretation:
Most Likely Diagnosis: HbS/β⁺-Thalassemia
- Expected HbS range: 70-80% 111
- The presence of residual HbA (typically 10-25%) distinguishes this from HbSS 1
- This genotype is associated with mild disease severity compared to HbSS 11
- Patients typically have higher baseline hemoglobin than HbSS (not the severe anemia of 60-90 g/L seen in HbSS) 11
Alternative Consideration: HbSS Disease
- Expected HbS range: 80-95% 111
- Associated with severe disease phenotype 11
- Baseline hemoglobin typically 60-90 g/L 11
- A 70% HbS in HbSS could occur if:
Less Likely: HbS/β⁰-Thalassemia
Critical Next Steps for Definitive Diagnosis
Review the complete HPLC report for:
HbA percentage:
HbF level:
HbA2 level:
Red cell indices from CBC:
Clinical Severity Assessment
The clinical phenotype matters more than the exact genotype for management:
- HbS/β⁺-thal (70-80% HbS): Mild phenotype, fewer painful crises, higher baseline Hb 11
- HbSS (80-95% HbS): Severe phenotype, early painful crises, severe anemia (Hb 60-90 g/L) 11
Key clinical discriminators:
- Age of symptom onset (early in HbSS, later in HbS/β⁺-thal)
- Frequency of painful crises
- Baseline hemoglobin level
- History of acute chest syndrome or stroke
- Transfusion history
Management Implications
For perioperative planning (if relevant):
Preoperative transfusion targets are individualized based on:
HbS/β⁺-thal patients may require exchange transfusion rather than simple transfusion if baseline Hb is already elevated, to avoid hyperviscosity 1
Common Pitfalls to Avoid
Don't rely solely on HbS percentage for diagnosis—always correlate with HbA presence, clinical phenotype, and family history 72
Recent transfusion can dramatically alter HPLC results—check transfusion history within past 3 months 12
HbA2 elevation in HbS-containing samples is an artifact of HPLC methodology, not necessarily indicative of β-thalassemia trait 2
Molecular genetic testing is definitive when phenotypic results are ambiguous 87
Recommend molecular genetic testing if: clinical severity doesn't match expected genotype, family planning is being considered, or HPLC pattern is atypical 87.